Max Robotics — Global Service Robot Directory + US Certification

About

Mary C. Farach-Carson is a distinguished biomedical researcher whose work lies at the intersection of extracellular matrix biology, cancer metastasis, and tissue engineering. She is best known for her pioneering contributions to understanding the role of the perlecan/HSPG2 proteoglycan in bone and prostate cancer biology, particularly how the tumor microenvironment influences metastatic progression. Her research has fundamentally shaped our understanding of how heparan sulfate proteoglycans regulate cell signaling, angiogenesis, and tumor-stromal interactions. With over 20,000 citations across her career, her impact is substantial. Notably, she was a key contributor to the landmark FANTOM5 consortium project (2017, 361 citations), which mapped transcription initiation events across thousands of human and mouse samples at single-base resolution using CAGE sequencing. This work provided an unprecedented resource for understanding gene regulation. A prolific author and educator, she has also made significant contributions to dental and craniofacial biology, and her work on hyaluronan and CD44 in cancer cell behavior has opened new avenues for therapeutic targeting. Her research continues to bridge basic extracellular matrix science with translational applications in cancer and regenerative medicine.